<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://brn.sagepub.com">
<title>Biological Research For Nursing recent issues</title>
<link>http://brn.sagepub.com</link>
<description>Biological Research For Nursing RSS feed -- recent issues</description>
<prism:publicationName>Biological Research For Nursing</prism:publicationName>
<prism:issn>1099-8004</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/10/1/5?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/7?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/21?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/34?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/44?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/54?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/10/1/63?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/9/4/269?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/9/4/271?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/4/272?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/4/280?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/4/293?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/4/301?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/4/311?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/185?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/9/3/200?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/9/3/203?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/205?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/215?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/223?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/231?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/244?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/3/254?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/reprint/9/3/264?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/97?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/108?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/117?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/130?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/142?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/147?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/161?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/9/2/170?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://brn.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://brn.sagepub.com:80/icons/banner/title.gif">
<title>Biological Research For Nursing</title>
<url>http://brn.sagepub.com:80/icons/banner/title.gif</url>
<link>http://brn.sagepub.com</link>
</image>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/10/1/5?rss=1">
<title><![CDATA[Skeletal Muscle Biology in Nursing]]></title>
<link>http://brn.sagepub.com/cgi/reprint/10/1/5?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Schneider, B. St. P.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408319057</dc:identifier>
<dc:title><![CDATA[Skeletal Muscle Biology in Nursing]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>6</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>5</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/7?rss=1">
<title><![CDATA[The Biological Mechanisms of Cancer-Related Skeletal Muscle Wasting: The Role of Progressive Resistance Exercise]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/7?rss=1</link>
<description><![CDATA[<p>Cancer results in perturbations in skeletal muscle protein metabolism leading to muscle wasting. Although severe wasting is seen primarily in persons with advanced malignancies, a number of cancer patients show some degree of wasting at presentation. Although cancer-related skeletal muscle wasting is attributable, in part, to decreased muscle protein synthesis, its primary cause appears to be increased muscle protein degradation. Although several proteolytic systems may be involved, compelling evidence suggests that the major system responsible for skeletal muscle protein degradation in cancer is the ATP-dependent ubiquitin&mdash; proteasome system. Other contributing factors include proinflammatory cytokines and the tumor-released proteolysis-inducing factor. Decreased physical activity and decreased nutritional intake may also play a role. Cancer-related skeletal muscle wasting is clinically significant because of its profound effects on functional outcomes and quality of life. Nevertheless, no specific interventions have proved to be effective in preventing or reversing the problem. Interventions such as nutritional supplementation and appetite stimulants are only partially helpful. A nonpharmacologic intervention that may attenuate cancer-related skeletal muscle wasting is progressive resistance exercise training (PRT). PRT is a potent stimulus of growth in muscle mass and strength. PRT may attenuate cancer-related skeletal muscle wasting by downregulating the activity of proinflammatory cytokines and by increasing the phosphorylation of intramuscular amino acid&mdash;signaling molecules. This article discusses several cancer-related skeletal muscle wasting mechanisms and proposes how PRT might attenuate muscle wasting by counteracting some of these mechanisms.</p>]]></description>
<dc:creator><![CDATA[Al-Majid, S., Waters, H.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408317345</dc:identifier>
<dc:title><![CDATA[The Biological Mechanisms of Cancer-Related Skeletal Muscle Wasting: The Role of Progressive Resistance Exercise]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>20</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>7</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/21?rss=1">
<title><![CDATA[Mobility Interventions to Improve Outcomes in Patients Undergoing Prolonged Mechanical Ventilation: A Review of the Literature]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/21?rss=1</link>
<description><![CDATA[<p>Survivors of critical illness often undergo an extended recovery trajectory. Reduced functional ability is one of several adverse outcomes of prolonged bed rest and mechanical ventilation during critical illness. Skeletal muscle weakness is known to be one of the major phenomena that account for reduced functional ability. Although skeletal muscle weakness is evident after prolonged mechanical ventilation (PMV), few studies have tested the benefits of various types of mobility interventions in this population. The purpose of this article is to review the published research on improving mobility outcomes in patients undergoing PMV. For this review, published studies were retrieved from MEDLINE, PubMed, CINAHL, and the Cochrane Database of Systematic Reviews from January 1990 to July 2007. A total of 10 relevant articles were selected that examined the effect of whole body physical therapy, electrical stimulation (ES), arm exercise, and inspiratory muscle training (IMT). Overall, there is support for the ability of mobility interventions to improve outcomes in patients on PMV but limited evidence of how to best accomplish this goal. Generating more data from multicenter studies and randomized controlled trials is recommended.</p>]]></description>
<dc:creator><![CDATA[Choi, J., Tasota, F. J., Hoffman, L. A.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408319055</dc:identifier>
<dc:title><![CDATA[Mobility Interventions to Improve Outcomes in Patients Undergoing Prolonged Mechanical Ventilation: A Review of the Literature]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>33</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>21</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/34?rss=1">
<title><![CDATA[An Aerobic Weight-Loaded Pilot Exercise Intervention for Breast Cancer Survivors: Bone Remodeling and Body Composition Outcomes]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/34?rss=1</link>
<description><![CDATA[<p>Objective. Weight gain and bone loss are commonly reported in breast cancer survivors. The purpose of this pilot study is to assess feasibility and explore the effect of an aerobic weight-loaded exercise intervention on bone remodeling, weight, and body composition.</p><p>Design. A one-group pre-posttest design was used to test a 16&mdash;24-week supervised walking exercise intervention among women within 2 years of menopause. Through Weeks 1&mdash;4, time and weight were progressively increased. By Week 5 and through the end of the intervention, a waist belt was loaded with 5 lb and participants spent 45 min on the treadmill 3 times/week. Bone remodeling was measured by serum biomarkers (N-terminal propeptides of type I collagen [NTX] and serum osteocalcin). Dual-energy absorptiometry scans assessed body composition. Data were collected at baseline and 16 and 24 weeks.</p><p>Results. The majority of the 26 participants were married, well educated, and employed, with a mean age of 51.3 years (SD = 6.2). The high adherence (M = 88.2%, SD = 6.8) demonstrated feasiblity. There were no significant changes in serum osteocalcin (p = .67), serum NTX (p = .31), lean muscle mass (p = .08), or percent fat mass for the group as a whole (p = .14), but fat mass increased for women on adjuvant endocrine therapy (p = .04). The women maintained their weight.</p><p>Conclusions. This novel exercise intervention for breast cancer survivors was feasible, and women otherwise at high risk for weight gain and bone loss maintained their weight and bone mass.</p>]]></description>
<dc:creator><![CDATA[Knobf, M. T., Insogna, K., DiPietro, L., Fennie, K., Thompson, A. S.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408320579</dc:identifier>
<dc:title><![CDATA[An Aerobic Weight-Loaded Pilot Exercise Intervention for Breast Cancer Survivors: Bone Remodeling and Body Composition Outcomes]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>43</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>34</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/44?rss=1">
<title><![CDATA[Wound Bioburden and Infection-Related Complications in Diabetic Foot Ulcers]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/44?rss=1</link>
<description><![CDATA[<p>The identification and diagnosis of diabetic foot ulcer (DFU) infections remains a complex problem. Because inflammatory responses to microbial invasion may be diminished in persons with diabetes, clinical signs of infection are often absent in persons with DFUs when infection is limited to localized tissue. In the absence of these clinical signs, microbial load is believed to be the best indicator of infection. Some researchers, however, believe microbial load to be insignificant and type of organism growing in the ulcer to be most important. Previous studies on the microbiology of DFUs have not provided enough evidence to determine the microbiological parameters of importance.</p><p>Infection-related complications of DFUs include wound deterioration, osteomyelitis, and amputation. Risk factors for amputation include age, peripheral vascular disease, low transcutaneous oxygen, smoking, and poor glycemic control. These risk factors are best measured directly with physiological measures of arterial perfusion, glycemic control, sensory neuropathy, plantar pressures, and activity level and by controlling off-loading. DFU bioburden has not been examined as a risk factor for infection-related complications. To address the relationship between wound bioburden and the development of infection-related complications in DFUs, tightly controlled prospective studies based on clearly defined, valid measures of wound bioburden and wound outcomes are needed. This article reviews the literature and proposes a model of hypothesized relationships between wound bioburden&mdash;including microbial load, microbial diversity, and pathogenicity of organisms&mdash;and the development of infection-related complications.</p>]]></description>
<dc:creator><![CDATA[Gardner, S. E., Frantz, R. A.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408319056</dc:identifier>
<dc:title><![CDATA[Wound Bioburden and Infection-Related Complications in Diabetic Foot Ulcers]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>53</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>44</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/54?rss=1">
<title><![CDATA[Bioassay Research Methodology: Measuring CRH in Pregnancy]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/54?rss=1</link>
<description><![CDATA[<p>Background. There are documented associations between elevated maternal corticotropin-releasing hormone (CRH) levels and adverse pregnancy outcomes. However, reports of these findings often lack sufficient detail and rationale regarding the bioassay methodology. This shortcoming can be problematic for researchers who do not possess in-depth laboratory sciences knowledge but who want to include bioassays in their investigations or to evaluate published reports. The quality and reliability of CRH measurement results can be significantly affected by variables encountered during sample collection, processing, storage, and bioassay. Thus, it is important to establish research laboratory protocols that are based on well-informed rationales and to carefully consider and control for relevant variables.</p><p>Approach. A synthesis of laboratory sciences literature regarding variables affecting CRH measurement in pregnancy is presented. Additionally, consultation with experienced researchers provided an in-depth understanding of CRH measurement. From these sources, a laboratory protocol for clinical research was developed.</p><p>Results. Multiple variables that are specific to the reliability of CRH measurement in pregnancy have been identified. These include sample collection methods, sample processing, sample integrity, sample storage, and the actual assay selected.</p><p>Conclusion. The reliability of CRH measurements can be significantly improved by identifying and controlling for variables encountered during sample collection, processing, storage, and bioassay. Adequate methodological details are difficult to glean solely from the published literature, thus consultation with well-informed researchers is necessary. A protocol for CRH bioassay in clinical research is proposed.</p>]]></description>
<dc:creator><![CDATA[Latendresse, G., Ruiz, R. J.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408320970</dc:identifier>
<dc:title><![CDATA[Bioassay Research Methodology: Measuring CRH in Pregnancy]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>62</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>54</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/10/1/63?rss=1">
<title><![CDATA[The Effect of Obesity on Heart Rate (Heart Period) and Physiologic Parameters During Pregnancy]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/10/1/63?rss=1</link>
<description><![CDATA[<p>Obesity and excess gestational weight gain (EGWG) in pregnancy increase the risk for adverse maternal and infant outcomes. Along with careful monitoring of weight gain during pregnancy, early identification of a maladaptive response to the changes of pregnancy may help to avoid adverse outcomes. Simple physiologic markers such as resting heart rate (HR), heart period (HP), and blood pressure (BP) may be powerful predictors of cardiovascular adaptation to pregnancy. This article summarizes the current state of the science regarding the effect of obesity (body mass index [BMI] ! 30 kg/m<sup>2</sup>) and EGWG in pregnant women at rest in laboratory settings. The impact of differences in weight gain (kg and BMI) on pregnancy outcomes is also examined. A search was conducted for articles published from 1985 to 2006 reporting data on body weight and HR or HP at rest from randomized controlled trials or controlled trials conducted in laboratory settings involving pregnant women at low or high risk for adverse pregnancy outcomes who were obese or had EGWG. A meta-analysis was conducted on the 23 studies meeting inclusion criteria to explore the relation of BMI to HR, HP, and physiologic parameters. Autonomic responsiveness was found to be diminished in obese women with a BMI > 30 kg/m<sup>2</sup> and in women with high risk for adverse pregnancy outcomes, which may indicate a maladaptive autonomic response that is imbalanced and disorganized and that reduces adaptation to environmental demands.</p>]]></description>
<dc:creator><![CDATA[Helmreich, R. J., Hundley, V., Varvel, P.]]></dc:creator>
<dc:date>2008-07-22</dc:date>
<dc:identifier>info:doi/10.1177/1099800408321077</dc:identifier>
<dc:title><![CDATA[The Effect of Obesity on Heart Rate (Heart Period) and Physiologic Parameters During Pregnancy]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>10</prism:volume>
<prism:endingPage>78</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>63</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/9/4/269?rss=1">
<title><![CDATA[T-Wave Alternans Magnitude, T-Wave Amplitude, and Heart Rate: Commentary on "Characterization of T Wave Alternans With Ambulatory Electrocardiography"]]></title>
<link>http://brn.sagepub.com/cgi/reprint/9/4/269?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Madias, J. E.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800408315161</dc:identifier>
<dc:title><![CDATA[T-Wave Alternans Magnitude, T-Wave Amplitude, and Heart Rate: Commentary on "Characterization of T Wave Alternans With Ambulatory Electrocardiography"]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>270</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>269</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/9/4/271?rss=1">
<title><![CDATA[Characterization of T Wave Alternans With Ambulatory Electrocardiography: Response to Commentary]]></title>
<link>http://brn.sagepub.com/cgi/reprint/9/4/271?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Harvey, M. B., Buchanan, J. W.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800408315339</dc:identifier>
<dc:title><![CDATA[Characterization of T Wave Alternans With Ambulatory Electrocardiography: Response to Commentary]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>271</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>271</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/4/272?rss=1">
<title><![CDATA[A Focused Microarray to Study Human Mitochondrial and Nuclear Gene Expression]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/4/272?rss=1</link>
<description><![CDATA[<p>A focused microarray (huMITOchip) was developed to study alterations of human mitochondrial and nuclear gene expression in health and disease. The huMITOchip contains 4,774 probe sets identical to the Affymetrix U 133 plus 2.0 chip covering genes affecting mitochondrial, lipid, cytokine, apoptosis, and muscle function transcripts. Unlike other gene chips, the huMITOchip has 51 probe sets that interrogate 37 genes of the mitochondrial genome. The human mitochondrial gene chip was validated against the Affymetrix U133 plus 2.0 array using an in vitro system of CCL136 muscle cell line stimulated with or without interferon gamma (IFN-). The 37 genes from the mtDNA demonstrated absolute gene expression levels ranging from 0.1 to 3,182. The comparison of the two gene chips yielded an excellent Pearson's correlation coefficient (<I>r</I> = 0.98). At least 17 probe sets were differentially expressed in response to IFN- on both chips, with a high degree of concordance. This is the first report on the development of a focused oligonucleotide microarray containing genes of the mitochondrial genome.</p>]]></description>
<dc:creator><![CDATA[Voss, J. G., Raju, R., Logun, C., Danner, R. L., Munson, P. J., Rangel, Z., Dalakas, M. C.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800408315160</dc:identifier>
<dc:title><![CDATA[A Focused Microarray to Study Human Mitochondrial and Nuclear Gene Expression]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>279</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>272</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/4/280?rss=1">
<title><![CDATA[Candidate Genes of the 5-Lipoxygenase Pathway in Acute Coronary Syndrome: A Pilot Study]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/4/280?rss=1</link>
<description><![CDATA[<p><I>Purpose.</I> The purpose of this pilot study was to examine arachidonate 5-lipoxygenase (ALOX5) and ALOX5-activating protein (ALOX5AP) gene variations in patients with and without acute coronary syndrome (ACS). <I>Methodology.</I> Four and six single nucleotide polymorphisms spanning the ALOX5 and ALOX5AP genes, respectively, were genotyped in 19 non-Hispanic Caucasian patients with ACS and 27 controls. <I>Results.</I> Presence of the common allele of rs9508835 (ALOX5AP) and the minor allele of rs2029253 (ALOX5) were associated with ACS. After adjustment for age, being a carrier of the rs9508835 common allele was associated with an increased risk of ACS (odds ratio = 2.86). <I>Relevance for nursing practice.</I> Through the inhibition of the ALOX5AP gene by downregulation of the leukotriene pathway, the risk of ACS may be decreased in individuals that carry susceptibility allele(s). Knowledge of the genetic basis of treatments that downregulate the leukotriene pathway may prove essential to the care of individuals with ACS.</p>]]></description>
<dc:creator><![CDATA[Wung, S.-F., Aouizerat, B. E.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800407313385</dc:identifier>
<dc:title><![CDATA[Candidate Genes of the 5-Lipoxygenase Pathway in Acute Coronary Syndrome: A Pilot Study]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>292</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>280</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/4/293?rss=1">
<title><![CDATA[Apoptotic-Related Protein Expression in the Diaphragm and the Effect of Dopamine During Inspiratory Resistance Loading]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/4/293?rss=1</link>
<description><![CDATA[<p>Dopamine (DA) is a free radical scavenger that attenuates apoptosis. We studied the effects of normal saline (NS) and DA on diaphragm apoptotic protein expression following 60 min of inspiratory resistance loading in rats. We tested for 27 apoptotic-related proteins and found 12 in the diaphragm. Of the 12 proteins, superoxide dismutase copper zinc (SOD [CuZn]) and proprioceptive event related potential (PERP) were significantly higher in the DA group than in the NS and sham groups (<I>p</I> = .002, <I>p</I> = .007). DA group diaphragms had significantly greater expression of SOD (CuZn) than the NS (<I>p</I> = .005) and sham group diaphragms (<I>p</I> = .003). Likewise, the DA group had significantly greater expression of PERP than the NS group (<I>p</I> = .008). These results suggest that DA decreases diaphragm apoptosis through elevated expression of SOD (CuZn). The identification of 12 apoptotic-related proteins will assist investigators as they study diaphragm apoptosis.</p>]]></description>
<dc:creator><![CDATA[Goodyear-Bruch, C. A., Jegathesan, J., Clancy, R. L., Pierce, J. D.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800408314573</dc:identifier>
<dc:title><![CDATA[Apoptotic-Related Protein Expression in the Diaphragm and the Effect of Dopamine During Inspiratory Resistance Loading]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>300</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>293</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/4/301?rss=1">
<title><![CDATA[Autonomic Tone in Medical Intensive Care Patients Receiving Mechanical Ventilation and During a CPAP Weaning Trial]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/4/301?rss=1</link>
<description><![CDATA[<p>Mechanical ventilator support and the resumption of spontaneous ventilation or weaning create significant alterations in alveolar and intrathoracic pressure that influence thoracic blood volume and flow. Compensatory autonomic tone alterations occur to ensure adequate tissue oxygen delivery, but autonomic responses may produce cardiovascular dysfunction with subsequent weaning failure. The authors describe autonomic responses of critically ill patients (<I>n</I> = 43) during a 24-hr period of mechanical ventilatory support and during the 24 hr that included their initial spontaneous breathing trial using continuous positive airway pressure. Nearly two thirds of these patients demonstrated abnormal autonomic function and this dysfunction was more severe in those patients who were unable to sustain spontaneous ventilation (<I>n</I> = 15). With further systematic study, autonomic responses may be useful in the identification of patients who are likely to develop cardiac dysfunction with the resumption of spontaneous breathing.</p>]]></description>
<dc:creator><![CDATA[Frazier, S. K., Moser, D. K., Schlanger, R., Widener, J., Pender, L., Stone, K. S.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800408314707</dc:identifier>
<dc:title><![CDATA[Autonomic Tone in Medical Intensive Care Patients Receiving Mechanical Ventilation and During a CPAP Weaning Trial]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>310</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>301</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/4/311?rss=1">
<title><![CDATA[Methotrexate-Induced Alterations in Beta-Oxidation Correlate With Cognitive Abilities in Children With Acute Lymphoblastic Leukemia]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/4/311?rss=1</link>
<description><![CDATA[<p>Treatment advances, including central nervous system (CNS) treatment with methotrexate, have led to significant gains in disease-free survival from childhood acute lymphoblastic leukemia (ALL). However, methotrexate has been associated with neurological problems such as declines in cognitive and academic abilities. The purpose of this study was to investigate methotrexate-induced changes in beta-oxidation in children with ALL receiving methotrexate for CNS treatment. Specific aims were to investigate effects of methotrexate on beta-oxidation of the two most prevalent fatty acids (palmitic acid and stearic acid) in cerebrospinal fluid (CSF) samples and correlate the ratio of monounsaturation to saturation of these fatty acids with cognitive and academic abilities. The sample included 12 females and 14 males with low-risk (<I>n</I> = 7), standard-risk (<I> n</I> = 13), or high-risk (<I>n</I> = 6) ALL. Mean age at diagnosis was 94.1 months (<I>SD</I> = 34.4). CSF samples were obtained in conjunction with diagnostic lumbar punctures; subsequent samples were obtained prior to intrathecal methotrexate administration during the induction, consolidation, and continuation phases of treatment. Fatty acids were analyzed by gas chromatography. Results showed a significant increase in the ratio of monounsaturation to saturation of both fatty acids, which was greatest during the most intensive phase of treatment. Ratios of monounsaturated to saturated fatty acids were negatively correlated with full-scale IQ, verbal IQ, and math calculations. Findings suggest that methotrexate alters beta-oxidation and that the resulting increase in fatty acid monounsaturation is related to declines in some domains of cognitive ability.</p>]]></description>
<dc:creator><![CDATA[Moore, I. M., Miketova, P., Hockenberry, M., Krull, K., Pasvogel, A., Carey, M., Kaemingk, K.]]></dc:creator>
<dc:date>2008-04-08</dc:date>
<dc:identifier>info:doi/10.1177/1099800407313268</dc:identifier>
<dc:title><![CDATA[Methotrexate-Induced Alterations in Beta-Oxidation Correlate With Cognitive Abilities in Children With Acute Lymphoblastic Leukemia]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>319</prism:endingPage>
<prism:publicationDate>2008-04-01</prism:publicationDate>
<prism:startingPage>311</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/185?rss=1">
<title><![CDATA[Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/185?rss=1</link>
<description><![CDATA[<p>Hereditary nonpolyposis colorectal cancer (HNPCC), also referred to as Lynch syndrome, is the most common form of hereditary colorectal cancer and is responsible for 2% to 4% of all colorectal cancers in the Western hemisphere. Generally characterized by early-onset colorectal carcinoma with a mean age of presentation of 40 to 45 years, it can also manifest with extracolonic adenocarcinomas and cancers of the endometrium, ovaries, stomach, pancreas, small intestine, hepatobiliary tract, upper uroepithelial tract, brain, and skin. HNPCC is autosomal dominant and carries an 80% lifetime risk of cancer development. This review addresses the molecular underpinnings of HNPCC while providing a concise approach to clinical detection, diagnosis, and management of patients who may or may not test positive for an HNPCC-causing mutation. Although applicable to any patient-care setting in which cancer may be observed, this review specifically addresses the role of nurses in detecting, diagnosing, and clinically managing HNPCC.</p>]]></description>
<dc:creator><![CDATA[Kurnat-Thoma, E. L.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407308558</dc:identifier>
<dc:title><![CDATA[Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>199</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>185</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/9/3/200?rss=1">
<title><![CDATA[Lynch Syndrome and the Role of the Registered Nurse: Commentary on "Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses"]]></title>
<link>http://brn.sagepub.com/cgi/reprint/9/3/200?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Lynch, H. T., Lynch, J. F.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309114</dc:identifier>
<dc:title><![CDATA[Lynch Syndrome and the Role of the Registered Nurse: Commentary on "Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses"]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>202</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>200</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/9/3/203?rss=1">
<title><![CDATA[Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Response to Commentary]]></title>
<link>http://brn.sagepub.com/cgi/reprint/9/3/203?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kurnat-Thoma, E. L.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309220</dc:identifier>
<dc:title><![CDATA[Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Response to Commentary]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>204</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>203</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/205?rss=1">
<title><![CDATA[Immune Responses to Guided Imagery During Breast Cancer Treatment]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/205?rss=1</link>
<description><![CDATA[<p><b>Background</b>: The use of relaxation and guided imagery to reduce stress and improve immune function has great potential benefits for patients with breast cancer. <b> Methods</b>: This pilot study used a pretest&mdash;posttest experimental design with 28 breast cancer patients, aged 25 to 75 years, with the diagnosis of stage 0, 1, or 2 breast cancer. The experimental group received a relaxation and guided imagery intervention and the control group received standard care. The effects of the intervention on immune function were measured by natural killer (NK) cell cytotoxicity and IL-2&mdash;activated NK cell activity prior to surgery and 4 weeks postsurgery. NK cell activity was measured using a 15-hr incubation chromium release assay. Cytotoxicity of NK cells was measured against chromium-labeled K-562 target cells. IL-2 was used to enhance reactivity of NK cells against tumor cells. After incubation for 15 hr, cytotoxicity was measured through the release of radioactive chromium. <b> Results</b>: Significant differences between groups were found at 4 weeks postsurgery. <I>T-</I>tests showed increased NK cell cytotoxicity for the intervention group at 100:1, 50:1, and 25:1 effector cell: target cell ratios (E:T) (<I>p</I> &lt; .01 to <I>p</I> &lt; .05) and increased activation for IL-2 at 100:1, 50:1, 25:1, and 12.5:1 (E:T) (<I>p</I> &lt; .01 to <I>p</I> &lt; .05) for the intervention group as compared to the control group. <b> Discussion</b>: These findings suggest that a relaxation intervention such as guided imagery could have an effect on NK cell cytotoxicity and NK cell cytotoxicity after activation with IL-2 in patients undergoing surgery for breast cancer.</p>]]></description>
<dc:creator><![CDATA[Lengacher, C. A., Bennett, M. P., Gonzalez, L., Gilvary, D., Cox, C. E., Cantor, A., Jacobsen, P. B., Yang, C., Djeu, J.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309374</dc:identifier>
<dc:title><![CDATA[Immune Responses to Guided Imagery During Breast Cancer Treatment]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>214</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>205</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/215?rss=1">
<title><![CDATA[Cervical and Vaginal Cytokine Determinations in Pregnant Women: Methodologic Issues]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/215?rss=1</link>
<description><![CDATA[<p>Investigations of the role cytokines play in preterm birth are complicated by a number of methodologic issues that arise as to the most feasible and efficient methods to measure cytokines. The purpose of this article is to review methodologic issues surrounding the measurement of vaginal and cervical cytokines, specifically IL-1&beta;, IL-6, and TNF-, in pregnant women experiencing preterm labor. Specifically, two quantification methods, weight and protein assay, and cytokine specimens from two different sites, vaginal and cervical, were compared. There were no significant correlations between cytokine levels using the protein versus weight quantification method. The weight method had more negative values and thus the protein quantification method was more accurate. There were high correlations between cervical and vaginal IL-1&beta; levels and IL-6 levels, but cervical and vaginal TNF- levels were not correlated.</p>]]></description>
<dc:creator><![CDATA[Gennaro, S., Raftery, N., Campbell, D., Shults, J.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309281</dc:identifier>
<dc:title><![CDATA[Cervical and Vaginal Cytokine Determinations in Pregnant Women: Methodologic Issues]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>222</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>215</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/223?rss=1">
<title><![CDATA[Characterization of T Wave Alternans With Ambulatory Electrocardiography]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/223?rss=1</link>
<description><![CDATA[<p>T wave alternans (TWA) is a marker of ventricular electrical instability considered to be predictive for ventricular tachyarrhythmias. Techniques have been developed to detect TWA at the &micro;v level as a method for arrhythmia risk stratification of persons at high risk for sudden cardiac death. Currently, TWA is typically calculated using spectral analysis, whereby TWA is presumed to assume characteristics of stationarity. In contrast, a nonspectral method known as modified moving average analysis is purported to detect transient TWA that would not be observed using a spectral approach. The purpose of this pilot study work was to establish the basic TWA signal properties obtained with a device developed by GE Medical Systems using a descriptive, correlational study design. Ambulatory electrocardiography (AECG) recordings (<I>N</I> = 24) were digitized and processed, and TWA was calculated via the modified moving average technique. Findings showed that noise was positively correlated with TWA in AECG channel 1 (<I>r</I> = .899, <I> p</I> &lt; .01) and AECG channel 2 (<I>r</I> = .758, <I>p</I> &lt; .01). However, no significant difference (<I>p</I> = .237) was observed in TWA values between the AECG channels. A weak positive correlation was found between TWA and heart rate, expressed as beats per min (<I>r</I> = .262). Heart rate mildly predicted TWA (<I>R</I> = 0.34). Nonstationarity was evaluated by testing for trend and randomness. TWA values measured from AECG recordings were found to be influenced moderately by noise and minimally by heart rate and lead placement.</p>]]></description>
<dc:creator><![CDATA[Harvey, M. B., Buchanan, J. W.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309741</dc:identifier>
<dc:title><![CDATA[Characterization of T Wave Alternans With Ambulatory Electrocardiography]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>230</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>223</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/231?rss=1">
<title><![CDATA[Sleep Disorders, Glucose Regulation, and Type 2 Diabetes]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/231?rss=1</link>
<description><![CDATA[<p>Recent epidemiological, biological, and behavioral evidence suggests that sleep disorders may contribute to the development of diabetes; conversely, diabetes itself may contribute to sleep disorders. Sleep appears to moderate the neurohormones that regulate blood glucose. Sleep deprivation and sleep disorders contribute to pathophysiological changes associated with the development of type 2 diabetes. In people who already have diabetes, sleep deprivation contributes to elevations of hemoglobin A1c. Symptoms that occur as a result of diabetes, such as nocturia and neuropathic pain, may in turn contribute to sleep disturbance and exacerbate sleep deprivation. The purposes of this article are to examine the scientific basis for the associations between diabetes and sleep, identify gaps in the understanding of the empirical underpinnings of these relationships, and propose directions for future research.</p>]]></description>
<dc:creator><![CDATA[Taub, L.-F. M., Redeker, N. S.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407311016</dc:identifier>
<dc:title><![CDATA[Sleep Disorders, Glucose Regulation, and Type 2 Diabetes]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>243</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>231</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/244?rss=1">
<title><![CDATA[Nocturnal Sleep and Daytime Nap Behaviors in Relation to Salivary Cortisol Levels and Temperament in Preschool-Age Children Attending Child Care]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/244?rss=1</link>
<description><![CDATA[<p>The purpose of this study was to describe nocturnal sleep and daytime nap duration in relation to salivary cortisol levels and child temperament in nonproblem nappers and problem nappers. Nighttime sleep and nap durations were obtained with continuous actigraph recordings for 3 days and nights (Tuesday, Wednesday, and Thursday) on 38 children aged 3 to 5 years who attended full-day child care centers. Nap times and disruptive behaviors were also observed and coded on each of the 3 days. Parents completed a temperament scale, sleep diaries, and the Children's Sleep Habits Questionnaire. Salivary cortisol samples were collected midmorning and in the afternoon after a nap on 2 consecutive days (Wednesday and Thursday). Problem napping and disruptive behaviors were associated with more negative affect, higher afternoon cortisol levels, and a smaller decrement in cortisol from morning to afternoon. Problem napping and disruptive behaviors were also associated with longer nighttime sleep, shorter nap durations, and later rise times. These data provide some insight into the associations among nighttime sleep, napping behavior, and salivary cortisol.</p>]]></description>
<dc:creator><![CDATA[Ward, T. M., Gay, C., Alkon, A., Anders, T. F., Lee, K. A.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407310158</dc:identifier>
<dc:title><![CDATA[Nocturnal Sleep and Daytime Nap Behaviors in Relation to Salivary Cortisol Levels and Temperament in Preschool-Age Children Attending Child Care]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>253</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>244</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/3/254?rss=1">
<title><![CDATA[A Randomized Clinical Trial of Elk Velvet Antler in Rheumatoid Arthritis]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/3/254?rss=1</link>
<description><![CDATA[<p>This article examines the effects of elk velvet antler on joint pain and swelling, patient/physician global assessment of disease activity, functional ability, quality of life, blood levels of C-reactive protein, and adverse events in persons with stage 2 to 3 rheumatoid arthritis experiencing residual symptoms after standard treatment. Patients (<I>N</I>=168) were enrolled in a 6-month randomized, triple-blind, placebo-controlled clinical trial. Instruments included the Arthritis Impact Measurement Scale, the Health Assessment Questionnaire, tender and swollen joint counts, and 100 mm-length visual analogue scales, along with blood tests. There were no significant differences between groups on any measures. The pattern of change of the measures across time points was essentially the same for both groups. Although some patients reported clinical improvements in their symptoms, there were no statistically significant differences between groups. Overall, elk velvet antler does not effectively manage residual symptoms in patients with rheumatoid arthritis.</p>]]></description>
<dc:creator><![CDATA[Allen, M., Oberle, K., Grace, M., Russell, A., Adewale, A. J.]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/1099800407309505</dc:identifier>
<dc:title><![CDATA[A Randomized Clinical Trial of Elk Velvet Antler in Rheumatoid Arthritis]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>261</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>254</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/reprint/9/3/264?rss=1">
<title><![CDATA[Erratum]]></title>
<link>http://brn.sagepub.com/cgi/reprint/9/3/264?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2007-12-12</dc:date>
<dc:identifier>info:doi/10.1177/10998004080090031101</dc:identifier>
<dc:title><![CDATA[Erratum]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>264</prism:endingPage>
<prism:publicationDate>2008-01-01</prism:publicationDate>
<prism:startingPage>264</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/97?rss=1">
<title><![CDATA[Tissue Factor: A Critical Role in Inflammation and Cancer]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/97?rss=1</link>
<description><![CDATA[<p>A series of coordinated enzymatic reactions takes place in the body whenever blood clots. The major physiological initiator of these reactions is a membrane-bound glycoprotein known as tissue factor (TF), which is normally separated from the bloodstream by the vascular endothelium. Bleeding, caused by injury or tissue damage, activates a complex enzyme cascade as TF becomes exposed to the bloodstream. In disease states, leukocytes or the vascular endothelium may abnormally express TF to cause intravascular coagulation. The blood-coagulation cascade is also relevant to diseases such as hemophilia, in which patients are deficient in blood proteins necessary for clotting, and is linked to vascular diseases such as heart attack and stroke, in which clotting can lead to the occlusion of blood vessels. Coagulation is also activated in inflammation and cancer. In this article, we discuss characteristics of TF and review its role in inflammation and cancer.</p>]]></description>
<dc:creator><![CDATA[Lwaleed, B. A., Cooper, A. J., Voegeli, D., Getliffe, K.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407305733</dc:identifier>
<dc:title><![CDATA[Tissue Factor: A Critical Role in Inflammation and Cancer]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>107</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>97</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/108?rss=1">
<title><![CDATA[C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/108?rss=1</link>
<description><![CDATA[<p><I>Background:</I> The majority of breast cancers originate in the epithelial lining of the breast ductal system. Premalignant cell damage in this lining may produce biochemical signals that deliver inflammatory proteins to the site. The presence of C-reactive protein (CRP) in nipple aspirate fluid (NAF) may reflect an inflammatory state indicative of a premalignant breast microenvironment. This study ascertained CRP's presence in NAF and evaluated if risk factors, as identified by the Gail model, were associated with NAF CRP levels among healthy women. <I>Design:</I> NAF CRP levels were assayed in 59 women. <I>Results:</I> CRP was present in NAF and significantly (<I>p</I> = .04) and positively related to breast cancer risk as predicted by the Gail model. <I>Conclusion:</I> CRP is differentially present in NAF and varies by Gail model risk factors. CRP in NAF holds promise as a noninvasive biomarker that detects a precarcinogenic breast ductal microenvironment and may contribute to the diagnosis of breast cancer early in the course of the disease when prognosis is most favorable.</p>]]></description>
<dc:creator><![CDATA[Lithgow, D., Nyamathi, A., Elashoff, D., Martinez-Maza, O., Covington, C.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407306426</dc:identifier>
<dc:title><![CDATA[C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>116</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>108</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/117?rss=1">
<title><![CDATA[The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/117?rss=1</link>
<description><![CDATA[<p>Individuals are capable of producing vitamin D with proper exposure to sunlight. However, several factors can interfere with the effectiveness of this process. Most sunscreens filter out UVB light, thus inhibiting vitamin D production. Individuals with more darkly pigmented skin have greater difficulty producing vitamin D because melanin acts as an effective natural sunscreen, requiring longer sun exposure to produce an adequate daily allotment of vitamin D. Additionally, solely breastfed infants whose mothers suffered from vitamin D deficiency or insufficiency when pregnant have smaller reserves of the nutrient and are at greater risk of developing nutritional rickets. Vitamin D deficiency leads to rickets, osteomalacia, and osteoporosis. Long-term vitamin D insufficiency can lead to paracrine effects such as type 1 diabetes, cancer, and multiple sclerosis. This article reviews the current literature on vitamin D deficiency and insufficiency and their relation to different disease states. Potential areas for research are discussed.</p>]]></description>
<dc:creator><![CDATA[Alpert, P. T., Shaikh, U.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407308057</dc:identifier>
<dc:title><![CDATA[The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>129</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>117</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/130?rss=1">
<title><![CDATA[A Feasibility Study of a Culturally Tailored Diabetes Intervention for Mexican Americans]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/130?rss=1</link>
<description><![CDATA[<p>Latinos, the fastest growing minority group in the United States, are among the hardest hit by diabetes. Among Latinos, Mexican Americans have the highest rate (23.9%) of diabetes. Good self-management can improve glycemic control and decrease diabetes complications but can be challenging to achieve. The purpose of this study was to test the feasibility and examine the effects of a culturally tailored intervention for Mexican Americans with type 2 diabetes on outcomes of self-management. The study used a pretest/posttest control group design with 10 participants in each group (<I>N</I> = 17). Feasibility and acceptability of the tailored diabetes self-management program was assessed by examining ease of recruitment and retention rates. The behavioral outcomes of self-efficacy, diabetes knowledge and self-care measures, and the biologic outcomes of weight, body mass index, HbA1C, and blood glucose were used to examine intervention effectiveness. Successful recruitment of participants came from personal referrals from providers or the <I>promotora</I>. Retention rates were 100% for the intervention group and 80% for the control group. Findings suggest that the intervention had a positive clinical and statistical effect on diabetes knowledge, weight, and body mass index. Improvements were also noted in self-efficacy scores, blood glucose, and HbA1C, but these changes did not reach statistical significance. A culturally tailored diabetes self-management program may result in improved outcomes for Mexican Americans with type 2 diabetes.</p>]]></description>
<dc:creator><![CDATA[Vincent, D., Pasvogel, A., Barrera, L.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407304980</dc:identifier>
<dc:title><![CDATA[A Feasibility Study of a Culturally Tailored Diabetes Intervention for Mexican Americans]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>141</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>130</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/142?rss=1">
<title><![CDATA[Use of General Clinical Research Centers for Nursing Research]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/142?rss=1</link>
<description><![CDATA[<p>This study examines to what extent academic nursing faculty members understand the purpose of general clinic research centers (GCRCs) and use this resource in their programs of research. GCRCs provide a controlled research-oriented infrastructure to conduct safe, innovative, and multidisciplinary studies. Survey questionnaires were sent to associate deans of research at schools of nursing accredited by the Commission on Collegiate Nursing Education or the National League for Nursing Accrediting Commission within 60 miles of a GCRC. They were asked to distribute questionnaires to 20% of faculty members. Of the 186 nurse faculty members responding, 85% had not conducted research at a GCRC as a principal investigator and 69% of the sample reported that their colleges or universities do not make information about GCRCs available to new faculty. Making greater use of this valuable resource allows nurse researchers to become more involved in developing new knowledge and testing interventions and in psychological and physiologic measurements, thus doing more to fulfill the mission of nursing research and increasing the involvement of nurses in the broader community of health science research.</p>]]></description>
<dc:creator><![CDATA[Payne, J. K., Yenser, S. E.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407307469</dc:identifier>
<dc:title><![CDATA[Use of General Clinical Research Centers for Nursing Research]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>146</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>142</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/147?rss=1">
<title><![CDATA[The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/147?rss=1</link>
<description><![CDATA[<p>Lifetime prevalence rates of depression are higher in women than men. Because this gender disparity appears after the onset of puberty and declines after menopause, gonadal hormones may play a role in women's increased vulnerability to dysphoric states. Estrogens have powerful effects beyond their role in reproduction. Fluctuations in estrogen occur naturally throughout the reproductive years and can be associated with disruptions in mood. Treatment for depression with exogenous estrogen has produced equivocal results. To shed light on the complex interactions among estrogens, serotonin, and mood, we briefly examine (a) central serotonin systems and their relationship to mood and mood disorders, (b) nonreproductive effects of estrogens on those systems, (c) potential points of intersection between serotonin systems and estrogens, and (d) research into the use of exogenous estrogen in depression in women. In conclusion, we reiterate the call for carefully controlled research into the etiology and treatment of depression in women.</p>]]></description>
<dc:creator><![CDATA[Lasiuk, G.C., Hegadoren, K.M.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407305600</dc:identifier>
<dc:title><![CDATA[The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>160</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>147</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/161?rss=1">
<title><![CDATA[Relationship of SERT Polymorphisms to Depressive and Anxiety Symptoms in Irritable Bowel Syndrome]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/161?rss=1</link>
<description><![CDATA[<p>This study investigates the association of psychological symptoms with the distribution of two serotonin transporter gene (SERT) polymorphisms, located in the promoter region (5-HTTLPR) and in intron 2 (STin2 VNTR), in patients with irritable bowel syndrome (IBS). Participants, 21 men and 117 women, were assessed for mental health history and current psychological distress. A blood sample was used for genotyping. Participants who were homozygous for the short allele of 5-HTTLPR or carried a STin2.9 VNTR allele were significantly more likely to have a history of depression. Participants did not differ by genotype in their history of anxiety or suicidal ideation nor in their current levels of depression, anxiety, or general psychological distress. The results support a biopsychosocial model of IBS in which SERT genotype modifies the risk for depressive episodes. Long term, practitioners may individualize treatment of patients with IBS using genotype as one of the factors.</p>]]></description>
<dc:creator><![CDATA[Jarrett, M. E., Kohen, R., Cain, K. C., Burr, R. L., Poppe, A., Navaja, G. P., Heitkemper, M. M.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407307822</dc:identifier>
<dc:title><![CDATA[Relationship of SERT Polymorphisms to Depressive and Anxiety Symptoms in Irritable Bowel Syndrome]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>169</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>161</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/9/2/170?rss=1">
<title><![CDATA[Direct Sequencing Is More Accurate and Feasible in Detecting Single Nucleotide Polymorphisms than RFLP: Using Human Vascular Endothelial Growth Factor Gene as a Model]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/9/2/170?rss=1</link>
<description><![CDATA[<p>Since the sequencing of the human genome, there has been increased interest in understanding the distribution and effects of genetic variations among individuals. Restriction fragment length polymorphism (RFLP) is a well-established and frequently used method for genotyping. This method, however, is indirect and has a number of limitations. It is thus important to reevaluate the use of RFLP in light of more contemporary methods of genotyping. The specific aims of this study are to (a) compare genotyping methods of traditional RFLP with contemporary direct sequencing for accurate identification of polymorphisms within the human vascular endothelial growth factor (VEGF) gene and (b) describe distribution of a known single nucleotide polymorphism (SNP) in the VEGF gene in a sample composed of 50 healthy volunteers. Polymerase chain reaction (PCR) was used to amplify the initial sample of DNA. Genotypes of a G-to-A substitution (GG, AG, AA) at -1154 were analyzed by RFLP and direct sequencing. RFLP was unable to discriminate among the three possible genotypes, whereas direct sequencing clearly identified genotype for all 50 samples. Observed genotype frequencies were comparable with the Hardy-Weinberg principle. This comparative study provides justification for selecting direct sequencing instead of RFLP for detecting SNPs in selected genes.</p>]]></description>
<dc:creator><![CDATA[Davis, A. H. T., Jianhua Wang,  , Tsang, T. C., Harris, D. T.]]></dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>info:doi/10.1177/1099800407308083</dc:identifier>
<dc:title><![CDATA[Direct Sequencing Is More Accurate and Feasible in Detecting Single Nucleotide Polymorphisms than RFLP: Using Human Vascular Endothelial Growth Factor Gene as a Model]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>9</prism:volume>
<prism:endingPage>178</prism:endingPage>
<prism:publicationDate>2007-10-01</prism:publicationDate>
<prism:startingPage>170</prism:startingPage>
<prism:section>Article</prism:section>
</item>

</rdf:RDF>